Related Experiment Videos
[Side effects of interferon alpha2a and b]
Annales De Dermatologie Et De Venereologie
|July 20, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Acute generalized exanthematous pustulosis: European expert consensus for diagnosis and management.
Journal of the European Academy of Dermatology and Venereology : JEADV·2024
"SCULP" study: The benefits of skin graft pellets on the pain of sickle cell leg ulcers (SCLU).
Journal de medecine vasculaire·2023
Performance accuracy, advantages and limitations of a store-and-forward teledermatology platform developed for general practitioners: A retrospective study of 298 cases.
Annales de dermatologie et de venereologie·2022
Antiphospholipid-negative Sneddon's syndrome: A comprehensive overview of a rare entity.
Annales de dermatologie et de venereologie·2021
Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs.
Annales de dermatologie et de venereologie·2021
2024 guidelines (S3) for the therapeutic management of patients with genital herpes.
Annales de dermatologie et de venereologie·2026
Topical JAK inhibitors in the lichen planus spectrum: a systematic review.
Annales de dermatologie et de venereologie·2026
2024 recommendations for the therapeutic management of anogenital warts.
Annales de dermatologie et de venereologie·2026
Depression and anxiety in visible skin diseases affecting the hands and face: a systematic literature review.
Annales de dermatologie et de venereologie·2026
HER2 inhibitors in the management of HER2-positive extramammary Paget's disease: a literature review.
Annales de dermatologie et de venereologie·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026